Show simple item record

dc.contributor.authorLaugharne, R
dc.contributor.authorWilcock, M
dc.contributor.authorRees, J
dc.contributor.authorWainwright, D
dc.contributor.authorNewton, N
dc.contributor.authorSterritt, J
dc.contributor.authorBadger, S
dc.contributor.authorBishop, R
dc.contributor.authorBassett, P
dc.contributor.authorShankar, R
dc.date.accessioned2023-12-02T00:03:46Z
dc.date.available2023-12-02T00:03:46Z
dc.date.issued2024-03
dc.identifier.issn0964-2633
dc.identifier.issn1365-2788
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/21766
dc.description.abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>People with intellectual disabilities (ID) die on an average 20 years earlier to the general population. They have higher rates of multimorbidity and polypharmacy. Around 25% of people with ID report chronic constipation. The England Learning Disabilities Mortality Review found that nearly 25% of deaths identified constipation as a long‐term health problem. However, the likely risk factors for constipation related harm are poorly enumerated. We sought to identify possible specific high‐risk factors by examining the clinical characteristics of people with ID admitted to hospital with constipation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Data of people with ID admitted with constipation in two general hospitals covering a population of 1.3 million from 2017 to 2022 were reported using the STROBE guideline for cohort studies. Collected data included age, gender, intellectual disability severity, recorded medication, presenting complaint and co‐morbidities. The medication anticholinergic burden was calculated using the anticholinergic burden scale. Continuous variables were summarised by mean and standard deviation if normally distributed, with categorical variables summarised by the number and percentage in each category.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 46 admissions (males 52%), 57% had moderate to profound ID, 37% had epilepsy, 41% prescribed antiseizure medication (ASM) and 45% were on laxatives. Average age was 46 years. The anticholinergic burden score mean was 2.3 and median, one.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We can hypothesise that people with more severe ID, suffering from epilepsy and on ASM may be more at risk of developing severe constipation. Some admissions may be avoided with earlier use of laxatives in the community.</jats:p></jats:sec>

dc.format.extent277-284
dc.format.mediumPrint-Electronic
dc.languageen
dc.publisherWiley
dc.subjectAnti-seizure medication
dc.subjectConstipation
dc.subjectDevelopmental disorder
dc.subjectGastrointestinal problems
dc.subjectLaxatives
dc.titleClinical characteristics of people with intellectual disability admitted to hospital with constipation: identifying possible specific high‐risk factors
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38031737
plymouth.issue3
plymouth.volume68
plymouth.publisher-urlhttp://dx.doi.org/10.1111/jir.13108
plymouth.publication-statusPublished
plymouth.journalJournal of Intellectual Disability Research
dc.identifier.doi10.1111/jir.13108
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Users by role
dc.publisher.placeEngland
dcterms.dateAccepted2023-10-30
dc.date.updated2023-12-02T00:03:46Z
dc.identifier.eissn1365-2788
dc.rights.embargoperiodforever
rioxxterms.versionofrecord10.1111/jir.13108


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV